Chapter 179: Xingtu Gene Company, which caused public outrage

American Empire, Broad Institute.

"Zhang Feng, you did a great job this time. The shareholders are very satisfied. You are sure to win the Nobel Prize this year,"

The director of the Broad Institute, Church, patted Zhang Feng on the shoulder with a hint of excitement in his eyes.

After all, everyone can see the future of 'Bode-001 AIDS specific drug'. It is a specific drug that can treat 2500 million AIDS patients.

It can be said that they can make tens of billions of dollars just by relying on this special medicine!
But soon, the expression of Church, the director of the Broad Institute, turned ugly. He sighed and said:

"It's a pity that Lin Feng doesn't understand business routines.

The 'EBT-002 gene therapy drug' he developed can slightly modify the patient's genes, making the patient immune to HIV for life after treatment.

This behavior is a disgrace to the medical community. His behavior is equivalent to cutting off the subsequent money-making path of AIDS. It is simply an unforgivable crime!"

There is an unwritten rule in the global pharmaceutical industry, which is that the drugs developed by everyone cannot be too effective.

For example, a normal person can perfectly cure a disease by taking a medicine with 10% efficacy.

After that, pharmaceutical companies will take the initiative to reduce the efficacy of their drugs under unwritten rules.

Weaken the efficacy of a drug that is 10% to 5 or 7%, achieving a certain effect, but without the ability to cure the disease immediately.

The ultimate goal of doing this is to get patients to buy more medicine.

After all, if a patient is cured after taking the medicine once, he or she will definitely not buy the medicine again.

However, the number of patients is limited. Since the number of patients cannot be greatly increased, pharmaceutical companies can only try their best to make enough money from the limited number of patients.

This is the unwritten rule in the global medical community.

Therefore, the global medical community actually hates and despises those kinds of miracle drugs that can hit the target with just one shot.

Especially the genetic medical drugs developed by Lin Feng that give patients lifelong immunity are disgusting.

For them, the best case scenario is that you take medicine every day, which can suppress the condition but cannot cure it immediately. This is the best case scenario.

Because in this way, patients will continue to buy drugs, contributing profits to pharmaceutical companies, and ultimately draining patients' savings and lives.

Now, the 'EBT-002 gene medical drug' launched by Xingtu Gene Company can not only cure AIDS in one shot, but also make people immune to AIDS for life.

This is equivalent to digging up the roots of everyone's continued earning money, which naturally aroused public anger.

Therefore, more than two months have passed, and the "EBT-002 gene medical drug" has still not been able to undergo clinical trials, and the date of its launch on the market is nowhere in sight.

The reason for all this is that pharmaceutical companies from various overseas countries are all trying their best to flatter Xingtu Gene and hold the company back.

“Director Church, Lin Feng is an extremely stupid person in business.

His biggest mistake was not developing a specific drug for AIDS, but making people immune to AIDS for life, which incurred public outrage. "

"Haha, great minds think alike."

After hearing this, Church, director of the Broad Institute, also laughed and said:

“Lin Feng’s act of making people immune to AIDS for life has successfully aroused hostility from pharmaceutical companies of all sizes around the world.

To tell you the truth, in order to punish Starway Genetics for not abiding by the unspoken rules, pharmaceutical companies around the world have secretly put pressure on local medical authorities.

Let Xingtu Gene's 'EBT-002 gene medical drug' follow the normal process and cannot be expedited for approval.

In the end, it took half a year for approval to conduct clinical trials, and then another half a year for continuous clinical trials, and finally a year before it was officially launched on the market. This also means that when Xingtu Gene's 'EBT-002 Gene Medical Drug' was launched on the market, our 'Bode-001 AIDS Specific Drug' had been on the market for more than 9 months.

During these 9 months, all the AIDS patients who could be treated were treated, and those who could not be treated were poor people or those who were unwilling to pay.

This means that we have eaten 39000 million of the 2500 million AIDS patients, three quarters of the pie...

All this is thanks to you, Zhang Feng, you deserve the Nobel Prize."

After finishing his speech, Church, the director of the Broad Institute, was also quite excited and spoke much more than before.

After all, when people make a lot of money, they will talk a lot and want to share their joy with others.

"It's all thanks to Director Church's support."

Zhang Feng was somewhat happy to be praised twice in a row, but his traditional Chinese cultural education still made him speak modestly.

Hearing this, Church smiled and said:

“After Lin Feng developed the gene enhancement drug, the U.S. military also wanted to develop its own gene enhancement drug.

But the military currently cannot afford much funding and can only invest a maximum of $1 billion.

Therefore, in the end, we still have to rely on our own research and development, and only when there are results will the military purchase genetic enhancement drugs on a large scale.

Do you have the confidence to develop your own genetic enhancement drug next?"

"Gene enhancement medicine? It would be impossible to develop this gene enhancement medicine within 20 years.

However, if we continue to use human lives to accumulate experience as before, and if there are thousands of scientific researchers specializing in the development of genetic enhancement drugs.

There is still a glimmer of hope that we can produce the first generation of gene enhancement drugs within five years, and then upgrade to the second generation of gene enhancement drugs within ten years."

Zhang Feng gave his answer.

After all, one's own business knows one's own business. As the first person in the West to use CRISPR/Cas9 gene editing technology, he is well aware of how advanced and magical the gene enhancement drug technology developed by Lin Feng is.

If you want to achieve the same effect as the gene-enhancing drug in the video, you must have a thorough understanding and mastery of every gene segment of the human being.

If you do not understand the secrets of human genes and forcibly transplant and replace someone's gene fragments, death due to genetic conflict is the inevitable outcome.

In this process, you need to use a large number of human lives to conduct experiments, and then find out why the experimenters died.

In this case, even if you overcome the transplantation and replacement of one gene fragment, if you add the second gene fragment.

The experimental subject will still die, and you still need to find out the reason and then overcome and solve the reason that caused the experimental subject's death.

This process of repeated failure and success requires the consumption of huge amounts of life as a price.

Although monkeys can be used as experimental subjects in the early stages, humans must be used as experimental subjects in the future.

Because monkeys will always be monkeys and humans will always be humans, they are ultimately two different species.

Therefore, if the monkeys' successful experiences are applied to humans, many of them will certainly be rendered invalid.

In the end, it is still necessary to use a large number of human lives as experimental subjects. This is the reality.

"Thousands of researchers, human experiments at all costs, and a minimum of five years of research and development time?"

Hearing Zhang Feng's words, the corners of Church's mouth twitched.

(End of this chapter)